Health Innovators: Teresa Arroyo-Gallego, nQ Medical


In this episode of our Health Innovators series, Paul Tunnah is joined by Teresa Arroyo-Gallego, chief data scientist at artificial intelligence technology company nQ Medical.

nQ Medical is developing technology to detect early signs of motor decline in diseases like Parkinson’s by monitoring how people type on their phones or computers. The company hope the technology can be applied to other disease areas including ALS, Alzheimer’s Disease and Multiple Sclerosis.

In this interview, Teresa tells Paul about the science behind the technology and how it could reshape the future of cognitive screening. She also discusses her views on AI, machine learning and digitalisation of healthcare, particularly in the wake of COVID and shares how digital platforms such as nQ Medical's technology could be used by patients in everyday life.


About the author

Dr Paul Tunnah is Chief Content Officer and UK Managing Director for Healthware Group, a next-generation integrated consulting group that operates at the intersection of the transformation of commercial operations and digital health, offering a unique range of services combining design, strategy, communication and innovation with technology and corporate venturing.

Prior to this, he founded pharmaphorum in 2009, which was acquired by Healthware Group in June 2020. He is a recognised author, speaker and industry advisor with a passion for helping organisations tell authentic stories that resonate, co-create solutions and unlock the power of digital and social media in connecting with customers and understanding markets. Dr Tunnah holds a BA in Biochemistry and DPhil in Biological Sciences from Oxford University.